Dr Ulrike Künzel is Associate Principal Scientist in the Functional Genomics team at AstraZeneca and the AstraZeneca lead for the Joint MRC-AZ-University of Cambridge Functional Genomics Screening Laboratory (FGSL). Uli has experience in arrayed CRISPR screening for target identification and target validation projects through her work at AstraZeneca. She is a cell biologist by training with a strong interest in applying CRISPR/Cas9 genome editing and complex disease-relevant models in the drug discovery process.
